{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360292619259979264.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1103849"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1103849"}}],"dc:title":[{"@value":"Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380292619259979267","@type":"Researcher","foaf:name":[{"@value":"David L. Porter"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619259979268","@type":"Researcher","foaf:name":[{"@value":"Bruce L. Levine"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619259979264","@type":"Researcher","foaf:name":[{"@value":"Michael Kalos"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619259979265","@type":"Researcher","foaf:name":[{"@value":"Adam Bagg"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619259979266","@type":"Researcher","foaf:name":[{"@value":"Carl H. June"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2011-08-25","prism:volume":"365","prism:number":"8","prism:startingPage":"725","prism:endingPage":"733"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1103849"}],"createdAt":"2011-08-10","modifiedAt":"2020-06-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335813622272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rise of iPSCs as a cell source for adoptive immunotherapy."}]},{"@id":"https://cir.nii.ac.jp/crid/1050003824759588608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002214562640768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Phase <scp>I</scp> clinical trial of adoptive transfer of expanded natural killer cells in combination with <scp>I</scp>g<scp>G</scp>1 antibody in patients with gastric or colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216004682624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome–positive acute lymphoblastic leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216808436224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218683428608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218684984960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218690523008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218954998016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230139148928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"<i>In vivo</i> antitumor function of tumor antigen‐specific CTLs generated in the presence of OX40 co‐stimulation <i>in vitro</i>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230482964736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In Vitro Generation of Antigen-Specific T Cells from Induced Pluripotent Stem Cells of Antigen-Specific T Cell Origin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232001570944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Highly efficient gene transfer using a retroviral vector into murine T cells for preclinical chimeric antigen receptor-expressing T cell therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239495711872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Interleukin-18 in Health and Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005518375807104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142846534784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168741854848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168869211392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optimization of lymphapheresis for manufacturing autologous CAR-T cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282465526784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Paving the road to make chimeric antigen receptor‐T‐cell therapy effective against solid tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017978256640896","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430624968960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evolution of natural killer cell-targeted therapy for acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691145285888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693667245312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693932510464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693959415424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283695889789440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283695890078208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706977528064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709237868032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Promising immunotherapies for esophageal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711319291264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711736741504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617624688768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617829533824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current status of cancer immunotherapy for gynecologic malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298754846174976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exhaustion of CAR T cells: potential causes and solutions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360300465355140096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated <scp>HEG1</scp>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865746798848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165445257728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Advances in personalized cancer immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166003387776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168636896000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179839575040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567180090729600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Whole blood interferon‐γ levels predict the therapeutic effects of adoptive T‐cell therapy in patients with advanced pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182096582528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"‘Off-the-shelf’ immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183348039680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183348158080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184629663616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adoptive transfer of genetically modified Wilms' tumor 1–specific T cells in a novel malignant skull base meningioma model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186773097728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567188579102080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gene-Modified Lymphocytes: From Caution to Promise for Effective Cancer Immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189465913984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor  Antigen-Specific Receptors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189643629056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092524968448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118805821824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232401185920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The histone demethylase Utx controls <scp>CD8</scp><sup>+</sup> T‐cell‐dependent antitumor immunity via epigenetic regulation of the effector function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340534172032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"RNA-Based Therapeutic Technology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641727513344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643620659200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643885028224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656450206208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658330667136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"All‐trans retinoic acid enhances cytotoxic effect of T cells with an anti‐CD38 chimeric antigen receptor in acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567363984896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cytotoxic CD8+ Lymphocytes in the Tumor Microenvironment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593737691776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294960065920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707148939136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel technologies for improving the safety and efficacy of CAR-T cell therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707381155968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855579838464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205078280064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"レトロウイルスベクターを用いた遺伝子治療：臨床治験での進展と安全性"},{"@language":"en","@value":"Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials"},{"@language":"ja-Kana","@value":"レトロウイルス ベクター オ モチイタ イデンシ チリョウ : リンショウチケン デ ノ シンテン ト アンゼンセイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205366524032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"S1-4. Progress in Regulatory Science: Gene Therapy"},{"@language":"ja","@value":"<b>４．レギュラトリーサイエンスの進歩：遺伝子治療</b>"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205420797696","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"同種移植におけるCAR-T細胞療法"},{"@language":"en","@value":"CAR-T cell therapy in combination with allogeneic stem cell transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206446149376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Recent Advances in Cell and Immunogene Therapy against Leukemia"},{"@language":"ja","@value":"2．白血病に対する細胞療法と免疫遺伝子治療"},{"@value":"白血病に対する細胞療法と免疫遺伝子治療"},{"@language":"ja-Kana","@value":"ハッケツビョウ ニ タイスル サイボウ リョウホウ ト メンエキ イデンシ チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390007216692548864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Revolution in Cancer Immunotherapy and its Perspective"},{"@language":"ja","@value":"がん免疫療法の急展開と今後の展望－消化器癌を中心に－"},{"@language":"ja-Kana","@value":"ガン メンエキ リョウホウ ノ キュウ テンカイ ト コンゴ ノ テンボウ ： ショウカキ ガン オ チュウシン ニ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679813214208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of Novel Anti-Cancer Immunotherapy Targeting Immune Evasion Mechanisms"},{"@value":"癌の免疫逃避機構を標的とした新しい治療法の研究と開発"},{"@language":"ja-Kana","@value":"ガン ノ メンエキ トウヒ キコウ オ ヒョウテキ トシタ アタラシイ チリョウホウ ノ ケンキュウ ト カイハツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390297504261178880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Gene Therapy for Cancer"},{"@language":"ja","@value":"癌の遺伝子治療"}]},{"@id":"https://cir.nii.ac.jp/crid/1390303343438340352","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Repeated Cytokine Releasing Syndrome During Nivolumab Plus Ipilimumab Therapy, with Bacterial Infection Suspected as a Trigger for Relapse"},{"@language":"ja","@value":"ニボルマブ＋イピリムマブ療法中にサイトカイン放出症候群を繰り返し，再燃の契機として細菌感染症が疑われた1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390586136190859264","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"がん治療用細胞製剤の開発―遺伝子改変を伴わない機能修飾―"},{"@language":"en","@value":"Development of Cellular Therapeutics for Cancer Treatment: Functional Enhancements Without Genetic Modification"},{"@language":"ja-Kana","@value":"ガン チリョウヨウ サイボウ セイザイ ノ カイハツ : イデンシ カイヘン オ トモナワナイ キノウ シュウショク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390848250110242304","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Approaching a New Era of Pemphigus Treatment"},{"@language":"ja","@value":"せまる天疱瘡治療の新時代"},{"@language":"ja-Kana","@value":"セマル テンポウソウ チリョウ ノ シン ジダイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1391975831220044032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1103849"},{"@type":"CROSSREF","@value":"10.1002/ijc.31285_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/nm.4431_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1182/blood-2011-12-398321_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1002/ijc.31244_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/978-1-4939-3338-9_6_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2222/jsv.65.27_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3390/ijms20030649_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/s41598-019-49834-2_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/2326-6066.cir-15-0060_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3892/ijo.2014.2634_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.omto.2021.03.001_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1093/intimm/dxab052_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s12185-021-03191-x_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1111/cas.15552_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2024.101003_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2482/haigan.65.54_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2745/dds.40.108_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s12185-024-03778-0_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1182/blood-2017-06-791202_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1186/2051-1426-1-21_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.4049/jimmunol.1402346_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.4049/jimmunol.1601494_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s13577-014-0089-8_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1080/14712598.2017.1315404_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1155/2012/853879_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1182/blood-2014-10-604777_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.7889/hct.6.1_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.exphem.2016.10.009_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.stem.2012.11.002_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/1078-0432.ccr-14-1559_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/2326-6066.cir-16-0043_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/mto.2016.24_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.jtho.2017.01.005_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2342/ymj.61.5_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3999/jscpt.43.175_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2336/nishinihonhifu.82.5_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s00262-021-02928-1_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1093/jjco/hyaa214_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1186/s12967-022-03442-3_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.omto.2022.07.006_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1182/bloodadvances.2022008327_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s12282-016-0688-1_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1002/ags3.12180_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1002/ijc.28117_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/bcj.2012.21_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/bcj.2016.30_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1093/neuonc/not007_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1186/s12885-018-5179-7_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2217/imt.12.1_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3390/ph7121049_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1155/2020/5825401_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.4049/jimmunol.2000768_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1272/manms.19.235_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1111/cas.15814_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3390/ijms242015230_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1002/ijc.34843_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1182/blood-2011-07-366419_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s12185-013-1493-7_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1038/cti.2016.73_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2013.07.030_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2169/naika.102.1751_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2016.03.054_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.2342/ymj.68.5_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/978-3-030-35723-8_4_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1111/cas.15074_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1007/s12185-022-03478-7_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3390/cancers15030601_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1615/critrevoncog.2023048735_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/0008-5472.can-12-1187_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.isci.2020.100998_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.3960/jslrt.20036_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/0008-5472.can-13-1365_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1158/2326-6066.cir-14-0186_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"},{"@type":"CROSSREF","@value":"10.1016/j.jcyt.2014.05.022_references_DOI_OH8noXkmDVqcSwXPU0BjzKRNiZn"}]}